Dartsbio Pharmaceuticals

Zhongshan, China · Founded 2017 · Privately Held (backing)

Developer of antibody drugs intended to improve the quality of life for cancer patients. Dartsbio Pharmaceuticals is based in Zhongshan, China and was founded in 2017. Its last reported valuation was $15.7 million in May 2020. It has raised $36 million.

Last reported valuation

$15.7M

Oct 2026

Priced at

—

Total raised

$36.0M

Last round

—

How much has Dartsbio Pharmaceuticals raised?

$36.0Macross 0 recorded rounds

Free account

More of Dartsbio Pharmaceuticals with a free account

·The complete investor list: 11 names
·Watch Dartsbio Pharmaceuticals: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Dartsbio Pharmaceuticals investors

11 investors are on record for Dartsbio Pharmaceuticals, including Guangdong Yuecai Venture Capital, Fuho Capital, Zhongshan Xiwan Investment Holding Development and Guangdong Gaowei Investment Management.

For fundraisers

Raising for a company like Dartsbio Pharmaceuticals?

11 investors have backed Dartsbio Pharmaceuticals.

See all 11 investors →

Frequently asked about Dartsbio Pharmaceuticals

How much has Dartsbio Pharmaceuticals raised?: Dartsbio Pharmaceuticals has raised $36.0M in total across 0 recorded funding rounds.